Predictive Factors for Functional and Quality of Life Decline in Patients >65 Years With a Gastrointestinal Tract Cancer Diagnosis Taken to Curative Resectable Surgery
Predictive Factors Associated With Functional Decline and Quality of Life Decline at 12 Months Follow-up and 5 Year Oncological Follow-up in Patients >65 Yares With a Gastrointestinal Tract Cancer Diagnosis Taken to Resectable Surgery With a Curative Intent in Hospital Universitario Mayor-Méderi, Bogotá, Colombia
1 other identifier
observational
327
1 country
1
Brief Summary
Introduction: Human life expectancy has increased significantly, leading to a transformation in the global demographic structure. Cancer is considerably more common among older adults compared to younger populations, as age is one of the main risk factors for its development. In fact, most solid tumors are considered age-related diseases. For this reason, the incidence of cancer among older individuals is expected to continue rising. Oncological care for this population group is particularly complex and represents a significant challenge, as comorbidities and the social aspects of aging create clinical scenarios that differ greatly from those seen in younger patients. Objective: To identify the predictive factors of functional decline and quality of life at 12 months of follow-up, as well as oncological outcomes at 5 years of follow-up, in patients aged 65 years and older with gastrointestinal cancer who undergo curative-intent resective surgery at Hospital Universitario Mayor - Méderi, Bogotá, Colombia. Methodology: Longitudinal and analytical observational study of prospective prognostic cohort type. Expected Results: Predictive model of functional decline and quality of life, as well as oncological outcomes, in patients with gastrointestinal cancer undergoing curative-intent surgical procedures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2026
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 13, 2026
CompletedFirst Submitted
Initial submission to the registry
February 9, 2026
CompletedFirst Posted
Study publicly available on registry
February 17, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 15, 2029
February 17, 2026
February 1, 2026
3.2 years
February 9, 2026
February 9, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Predictive factors associated with functional and quality of life decline at 12 months
Factors associated with functional and quality of life decline at 12 months follow-up
12 months
Predictive factors associated with oncological outcomes
Predictive factors associated with oncological outcomes
5 years
Secondary Outcomes (8)
Population characterization
5 years
Surgical and functional outcomes
1 year
Oncological outcomes
5 years
Comparison
1 year
Qualitative evaluation
1 year
- +3 more secondary outcomes
Study Arms (1)
Patients aged over 65 years with a gastrointestinal tract cancer diagnosis
Patients aged over 65 years with a gastrointestinal tract cancer diagnosis that are taken to surgery with a curative intent.
Eligibility Criteria
Patients ≥65 years of age with a gastrointestinal tract cancer diagnosis taken to surgery with a curative intent in the Hospital Universitario Mayor - Méderi, Bogotá, Colombia.
You may qualify if:
- Gastrointestinal cancer tract diagnosis (oesophagus, stomach, duodenum, pancreas, liver, biliary tract, small bowel, appendix, colon and rectum)
- Have resectable disease by surgery
- Taken to surgery by curative intent
- Willingness to participate and enrollment by informed consent
- Attended in the Mederi Hospital Networn
You may not qualify if:
- Mortality
- Loss to follow-up
- Not taken to surgery
- Emergency surgery
- Taken to surgery as an oncological relapse or due to complications previous to an index procedure
- Endoscopical treatment
- Second primary tumor without a minimum 5 year disease free period from the primary one
- Basal functionality 0/6 by Katz score.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Universitario Mayor-Méderi
Bogotá, Colombia
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 5 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 9, 2026
First Posted
February 17, 2026
Study Start
January 13, 2026
Primary Completion (Estimated)
March 31, 2029
Study Completion (Estimated)
December 15, 2029
Last Updated
February 17, 2026
Record last verified: 2026-02